Makroprolaktinemi tanısı için alternatif yöntemler: İdrar prolaktin düzeyi ve serum / idrar prolaktin oranı
Amaç: Bu çalışmanın amacı makroprolaktinemi tanısında idrar prolaktin ve serum / idrar prolaktin oranının doğruluğunu araştırmaktır. Yöntemler: Kesitsel analiz olan çalışmamızda, reprodüktif dönemdeki kadın ve erkeklerden prolaktin düzeyi bakılan (yüksek veya normal) hastalar çalışmaya alındı. Makroprolaktinemi tespiti için polietilen glikol (PEG) ile çöktürme yöntemi kullanıldı. Daha sonra hastalar makroprolaktinemi, prolaktinoma ve sağlıklı kontrol grubu olmak üzere üç gruba ayrıldı. Hastalarda eş zamanlı serum prolaktin ve spot idrarda prolaktin çalışıldı. Non-parametrik test olan Kruskal-Wallis testi grupların karşılaştırılmasında kullanıldı. Serum/idrar prolaktin oranının prediktif gücünü değerlendirmek için “receiver-operating characteristic (ROC)” eğrisi belirlendi ve bu analizde “cut-off” değeri elde edildi. Sonuçlar: Çalışmaya toplam 41 hasta dahil edildi. Kadın/erkek: 36 (%87,8) / 5 (%12,2). İdrar prolaktin medyan (minimum-maksimum) değerleri makroprolaktinemi, prolaktinoma ve kontrol grubunda sırasıyla; 0.06(0.05-0.10), 0.11(0.02-0.95), 0.08(0.05-0.25) ng/ml idi. Serum/idrar prolaktin oranı medyan (minimum-maksimum) değerleri makroprolaktinemi, prolaktinoma ve kontrol grubunda sırasıyla; 633(51-1032), 990(104-9635), 395.5(138-953) idi. Gruplar karşılaştırıldığında prolaktinoma olan hastalar daha yüksek üriner prolaktin seviyelerine sahipti. Makroprolaktinemili hastalar en düşük idrar prolaktin değerlerine sahipti(p
Alternative methods for the diagnosis of macroprolactinemia: urine prolactin level and serum / urine prolactin ratio
Objective: The aim of this study was to investigate the urine prolactin and serum/urine prolactin ratio for accuracydiagnosis of macroprolactinemia.Methods: In the retrospective cross-sectional analysis, prolactin levels (high or normal) in the reproductive period ofmen and women were included in the study. Polyethylene glycol (PEG) precipitation method was used for thedetection of macroprolactinemia. Then, patients were divided into three groups as macroprolactinemia, prolactinomaand healthy control group. In patients, prolactin values in spot urine with simultaneous serum prolactin values werecalculated. The non-parametric Kruskal-Wallis test was used to compare the groups. The receiver-operatingcharacteristic (ROC) curve was determined to evaluate the predictive power of serum/urine prolactin ratio.DOI: 10.5798/dicletip.534848Yazışma Adresi / Correspondence Zafer Pekkolay, Dicle University Faculty of Medicine ,Department of Internal Medicine-Endocrinology, Sur,Diyarbakir, Turkey e-mail: drpekkolay@gmail.comResults: A total of 41 patients were included in the study. Female/male:36 (87.8%)/ 5 (12.2%). Urinary prolactinmedian(minimum-maximum) values were macroprolactinemia, prolactinoma and control group, respectively;0.06(0.05-0.10), 0.11(0.02-0.95), 0.08(0.05-0.25) ng/ml. Serum/urine ratio median (minium-maximum) values weremacroprolactinemia, prolactinoma, and control group, respectively; 633(51-1032), 990(104-9635), 395.5(138-953).When the groups were compared, the patients with prolactinoma had higher urinary prolactin levels(p
___
- Horseman ND and Gregerson KA. Prolactin actions.
Journal of Molecular Endocrinology. 2014; 52: 95-106.
- Melmed S, Casanueva FF, Hoffman AR, et all. Endocrine
Society. Diagnosis and treatment of
hyperprolactinemia: an Endocrine Society clinical
practice guideline. J Clin Endocrinol Metab. 2011; 96:
273-88.
- Freeman ME, Kanyicska B, Lerant A, et all. Prolactin:
structure, function, and regulation of secretion.
Physiological Reviews. 2000; 80: 1523–631.
- Molitch ME. Prolactin in human reproduction In:
Strauss JF, Barbieri R, eds. Yen and Jaffe's reproductive
endocrinology: physiology, pathophysiology, and
clinical management, 7th edn. Elsevier Saunders,
Philadelphia 2014: 45-65.
- Hattori N, Ishihara T, Saiki Y, et all.
Macroprolactinaemia in patients with
hyperprolactinaemia: composition of macroprolactin
and stability during long-term follow-up. Clin
Endocrinol (Oxf). 2010; 73: 792–7.
- Hattori N, Nakayama Y, Kitagawa K, et all. Antiprolactin
(PRL) autoantibody-binding sites (epitopes)
on PRL molecule in macroprolactinemia. Clin
Endocrinol (Oxf). 2006; 190: 287-93.
- Freeman ME, Kanyicska B, Lerant A, et all. Prolactin:
structure, function, and regulation of secretion. Physiol
Rev. 2000;80:1523–631.
- Samson SL, Hamrahian AH, Ezzat S. American
Association of Clinical Endocrinologists. American
College of Endocrinology disease state clinical review:
clinical relevance of macroprolactin in the absence or
presence of true hyperprolactinemia. Endocr Pract.
2015; 21: 1427–35.
- Hattori N, Ishihara T, Saiki Y, et all.
Macroprolactinaemia in patients with
hyperprolactinaemia: composition of macroprolactin
and stability during long-term follow-up. Clinical
Endocrinology. 2010; 73: 792–7.
- Jamaluddin FA, Sthaneshwar P, Hussein Z, et all.
Importance of screening for macroprolactin in all
hyperprolactinaemic sera. Malays J Patho. 2013; 35:
59–63.
- Leslie H, Courtney CH, Bell PM, et all. Laboratory and
clinical experience in 55 patients with
macroprolactinemia identified by a simple
polyethylene glycol precipitation method. J Clin
Endocrinol Metab. 2001; 86: 2743-6.
- Silva AM, Costa da PM, Pacheco A, et all. Assessment
of macroprolactinemia by polyethylene glycol
precipitation method. Revista Portuguesa de
Endocrinologia, Diabetes e Metabolismo 2014; 9: 25-
28.
- Snyder PJ, Causes of hyperprolactinemia.
https://www.uptodate.com/contents/causes of
hyperprolactinemia.
- Smith TP, Kavanagh L, Healy ML, et all. Technology
insight: measuring prolactin in clinical samples. Nature
Reviews Endocrinology. 2007; 3: 279-89.
- Coppedge RL , Segaloff A. Urinary Prolactin Excretion
In Man, The Journal Of Clinical Endocrinology &
Metabolism. 1951; 11: 465–76.
- Leaños-Miranda A, Márquez-Acosta J, CárdenasMondragón
GM, et all. Urinary prolactin as a reliable
marker for preeclampsia, its severity, and the
occurrence of adverse pregnancy outcomes. J Clin
Endocrinol Metab. 2008; 93: 2492-9.
- Keely EJ, Charles F. Measurement of human urinary
prolactin as a noninvasive study tool. Clinical
chemistry. 1994; 40: 2017-21.